| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| INZY | Inozyme Pharma, Inc. | Bolte Axel | Director | Mar 31, 2023 | Option Exercise | $2.21 | 4,806 | 10,621 | 266,696 | Apr 04, 2023, 08:40 AM | |
| INZY | Inozyme Pharma, Inc. | Bolte Axel | Chief Executive Officer | Sep 30, 2022 | Option Exercise | $2.28 | 3,315 | 7,558 | 261,890 | Oct 04, 2022, 08:00 AM | |
| INZY | Inozyme Pharma, Inc. | Bolte Axel | Chief Executive Officer | Apr 19, 2022 | Buy | $3.69 | 67,750 | 249,998 | 258,575 | Apr 20, 2022, 04:05 PM | |
| INZY | Inozyme Pharma, Inc. | Bolte Axel | Chief Executive Officer | Jun 24, 2021 | Sale | $0.49 | 133,576 | 65,459 | 257,613 | Jun 25, 2021, 07:58 AM | |
| OPHT | Ophthotech Corp. | Bolte Axel | Director | Dec 30, 2016 | Sale | $4.83 | 6,000 | 28,980 | 0 | Jan 23, 2017, 05:05 PM | |
| OPHT | Ophthotech Corp. | Bolte Axel | Director | Jun 03, 2016 | Buy | $56.97 | 3,500 | 199,395 | 6,000 | Jun 07, 2016, 05:06 PM | |
| OPHT | Ophthotech Corp. | Bolte Axel | Director | Mar 30, 2015 | Buy | $48.27 | 500 | 24,135 | 2,500 | Apr 01, 2015, 05:54 PM | |
| OPHT | Ophthotech Corp. | Bolte Axel | Director | Sep 25, 2013 | Buy | $22.00 | 2,000 | 44,000 | 2,000 | Oct 07, 2013, 08:53 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Bolte Axel | Director | Jun 25, 2013 | Buy | $15.00 | 20,000 | 300,000 | 20,000 | Jun 27, 2013, 09:33 PM |
Menu